1	Acute	Acute	B-NP	JJ	O	3	NMOD
2	inflammatory	inflammatory	I-NP	JJ	O	3	NMOD
3	response	response	I-NP	NN	O	0	ROOT
4	in	in	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	stomach	stomach	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	BALB/c	BALB/c	B-NP	NN	O	9	NMOD
9	mice	mouse	I-NP	NNS	O	7	PMOD
10	challenged	challenge	B-VP	VBN	O	9	NMOD
11	with	with	B-PP	IN	O	10	VMOD
12	coccoidal	coccoidal	B-NP	JJ	O	14	NMOD
13	Helicobacter	Helicobacter	I-NP	NN	O	14	NMOD
14	pylori	pylori	I-NP	NN	O	11	PMOD
15	.	.	O	.	O	3	P

1	An	An	B-NP	DT	O	4	NMOD
2	experimental	experimental	I-NP	JJ	O	4	NMOD
3	murine	murine	I-NP	JJ	O	4	NMOD
4	model	model	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	used	use	I-VP	VBN	O	5	VC
7	to	to	B-VP	TO	O	8	VMOD
8	verify	verify	I-VP	VB	O	6	VMOD
9	the	the	B-NP	DT	O	12	NMOD
10	viability	viability	I-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	pathogenicity	pathogenicity	I-NP	NN	O	8	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	coccoid	coccoid	B-NP	NN	O	16	NMOD
15	Helicobacter	Helicobacter	I-NP	NN	O	16	NMOD
16	pylori	pylori	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	5	P

1	For	For	B-PP	IN	O	8	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	purpose	purpose	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	8	P
5	27	27	B-NP	CD	O	7	NMOD
6	BALB/c	BALB/c	I-NP	NN	O	7	NMOD
7	mice	mouse	I-NP	NNS	O	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	inoculated	inoculate	I-VP	VBN	O	8	VC
10	intragastrically	intragastrically	B-ADVP	RB	O	9	VMOD
11	with	with	B-PP	IN	O	9	VMOD
12	1	1	B-NP	CD	O	13	NMOD
13	ml	ml	I-NP	NN	O	15	NMOD
14	broth	broth	I-NP	CC	O	15	NMOD
15	culture	culture	I-NP	NN	O	11	PMOD
16	(	(	O	(	O	20	DEP
17	10	10	B-NP	CD	O	20	DEP
18	(	(	O	(	O	20	DEP
19	8	8	B-NP	CD	O	20	DEP
20	)	)	O	)	O	15	NMOD
21	organisms/ml	organisms/ml	B-NP	NN	O	15	NMOD
22	)	)	O	)	O	9	VMOD
23	of	of	B-PP	IN	O	9	VMOD
24	a	a	B-NP	DT	O	29	NMOD
25	coccoid	coccoid	I-NP	JJ	O	29	NMOD
26	H.	H.	I-NP	NN	O	29	NMOD
27	pylori	pylori	I-NP	NN	O	29	NMOD
28	clinical	clinical	I-NP	JJ	O	29	NMOD
29	isolate	isolate	I-NP	NN	O	23	PMOD
30	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	animals	animal	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	divided	divide	I-VP	VBN	O	3	VC
5	into	into	B-PP	IN	O	4	VMOD
6	two	two	B-NP	CD	O	7	NMOD
7	groups	group	I-NP	NNS	O	5	PMOD
8	.	.	O	.	O	3	P

1	Nine	Nine	B-NP	CD	O	2	SUB
2	were	be	B-VP	VBD	O	13	VMOD
3	infected	infect	I-VP	VBN	O	2	VC
4	on	on	B-PP	IN	O	3	VMOD
5	a	a	B-NP	DT	O	7	NMOD
6	one-time	one-time	I-NP	JJ	O	7	NMOD
7	basis	basis	I-NP	NN	O	4	PMOD
8	(	(	O	(	O	10	DEP
9	GA1	GA1	B-NP	NN	B-protein	10	DEP
10	)	)	O	)	O	7	NMOD
11	and	and	O	CC	O	13	VMOD
12	18	18	B-NP	CD	O	13	SUB
13	were	be	B-VP	VBD	O	0	ROOT
14	infected	infect	I-VP	VBN	O	13	VC
15	on	on	B-PP	IN	O	14	VMOD
16	two	two	B-NP	CD	O	18	NMOD
17	consecutive	consecutive	I-NP	JJ	O	18	NMOD
18	days	day	I-NP	NNS	O	15	PMOD
19	(	(	O	(	O	21	DEP
20	GA2	GA2	B-NP	NN	B-protein	21	DEP
21	)	)	O	)	O	18	NMOD
22	.	.	O	.	O	13	P

1	Other	Other	B-NP	JJ	O	3	NMOD
2	27	27	I-NP	CD	O	3	NMOD
3	mice	mouse	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	17	VMOD
5	inoculated	inoculate	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	Brucella	Brucella	B-NP	NNP	O	8	NMOD
8	broth	broth	I-NP	NN	O	6	PMOD
9	and	and	O	CC	O	5	VMOD
10	divided	divide	B-VP	VBN	O	5	VMOD
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	same	same	I-NP	JJ	O	14	NMOD
14	way	way	I-NP	NN	O	11	PMOD
15	;	;	O	:	O	4	P
16	they	they	B-NP	PRP	O	17	SUB
17	composed	compose	B-VP	VBD	O	0	ROOT
18	the	the	B-NP	DT	O	20	NMOD
19	control	control	I-NP	NN	O	20	NMOD
20	group	group	I-NP	NN	O	17	OBJ
21	.	.	O	.	O	17	P

1	Mice	Mouse	B-NP	NNS	O	2	SUB
2	were	be	B-VP	VBD	O	0	ROOT
3	killed	kill	I-VP	VBN	O	2	VC
4	at	at	B-PP	IN	O	3	VMOD
5	2	2	B-NP	CD	O	14	NMOD
6	,	,	I-NP	,	O	14	P
7	3	3	I-NP	CD	O	14	NMOD
8	,	,	I-NP	,	O	14	P
9	7	7	I-NP	CD	O	14	NMOD
10	,	,	I-NP	,	O	14	P
11	14	14	I-NP	CD	O	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	21	21	I-NP	CD	O	14	NMOD
14	days	day	I-NP	NNS	O	4	PMOD
15	post	post	B-PP	IN	O	3	VMOD
16	inoculation	inoculation	B-NP	NN	O	15	PMOD
17	(	(	O	(	O	19	DEP
18	pi	pi	B-NP	NN	O	19	DEP
19	)	)	O	)	O	16	NMOD
20	.	.	O	.	O	2	P

1	Fragments	Fragment	B-NP	NNS	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	stomach	stomach	B-NP	NN	O	5	NMOD
4	and	and	I-NP	CC	O	5	NMOD
5	duodenum	duodenum	I-NP	NN	O	2	PMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	collected	collect	I-VP	VBN	O	6	VC
8	,	,	O	,	O	7	P
9	fixed	fix	B-VP	VBN	O	7	VMOD
10	with	with	B-PP	IN	O	9	VMOD
11	12	12	B-NP	CD	O	12	AMOD
12	%	%	I-NP	NN	O	13	NMOD
13	formalin	formalin	I-NP	NN	O	10	PMOD
14	and	and	O	CC	O	7	VMOD
15	stained	stain	B-VP	VBN	O	7	VMOD
16	by	by	B-PP	IN	O	15	VMOD
17	hematoxilin-eosin	hematoxilin-eosin	B-NP	NN	B-protein	16	PMOD
18	and	and	O	CC	O	19	VMOD
19	Giemsa	Giemsa	B-NP	NNP	O	6	VMOD
20	for	for	B-PP	IN	O	19	NMOD
21	histopathological	histopathological	B-NP	JJ	O	22	NMOD
22	examination	examination	I-NP	NN	O	20	PMOD
23	.	.	O	.	O	6	P

1	Until	Until	B-PP	IN	O	11	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	14th	14th	I-NP	JJ	O	1	PMOD
4	(	(	O	(	O	5	DEP
5	)	)	O	)	O	3	NMOD
6	day	day	B-NP	NN	O	3	NMOD
7	,	,	O	,	O	11	P
8	only	only	B-NP	RB	O	10	NMOD
9	reinfected	reinfected	I-NP	JJ	O	10	NMOD
10	mice	mouse	I-NP	NNS	O	11	SUB
11	had	have	B-VP	VBD	O	0	ROOT
12	mild-to-moderate	mild-to-moderate	B-NP	JJ	O	13	AMOD
13	inflammatory	inflammatory	I-NP	JJ	O	14	NMOD
14	infiltrate	infiltrate	I-NP	NN	O	11	OBJ
15	in	in	B-PP	IN	O	11	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	stomach	stomach	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	2	NMOD
2	infiltration	infiltration	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	predominantly	predominantly	B-ADJP	RB	O	5	AMOD
5	lymphomonocytic	lymphomonocytic	I-ADJP	JJ	O	3	PRD
6	,	,	O	,	O	3	P
7	although	although	B-SBAR	IN	O	3	VMOD
8	plasma	plasma	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	11	NMOD
10	and	and	O	CC	O	11	NMOD
11	eosinophils	eosinophil	B-NP	NNS	B-cell_type	12	SUB
12	could	could	B-VP	MD	O	7	SBAR
13	be	be	I-VP	VB	O	12	VC
14	seen	see	I-VP	VBN	O	13	VC
15	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	at	at	B-PP	IN	O	10	VMOD
4	21st	21st	B-NP	JJ	O	5	NMOD
5	day	day	I-NP	NN	O	3	PMOD
6	,	,	O	,	O	10	P
7	severe	severe	B-NP	JJ	O	8	AMOD
8	eosinophilic	eosinophilic	I-NP	JJ	O	9	NMOD
9	infiltration	infiltration	I-NP	NN	O	10	SUB
10	was	be	B-VP	VBD	O	0	ROOT
11	present	present	B-ADJP	JJ	O	10	PRD
12	in	in	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	17	NMOD
14	lamina	lamina	I-NP	NN	O	15	NMOD
15	propria	propria	I-NP	NN	O	17	NMOD
16	and	and	I-NP	CC	O	17	NMOD
17	submucosa	submucosa	I-NP	NN	O	12	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	gastric	gastric	B-NP	JJ	O	20	NMOD
20	corpus	corpus	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	6	VMOD
2	subgroup	subgroup	B-NP	NN	O	3	NMOD
3	GA1	GA1	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	animals	animal	B-NP	NNS	O	6	SUB
6	presented	present	B-VP	VBD	O	0	ROOT
7	lymphomonocytic	lymphomonocytic	B-NP	JJ	O	8	NMOD
8	infiltration	infiltration	I-NP	NN	O	6	OBJ
9	in	in	B-PP	IN	O	6	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	stomach	stomach	I-NP	NN	O	9	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	14th	14th	B-NP	JJ	B-DNA	17	NMOD
14	(	(	O	(	I-DNA	15	DEP
15	)	)	O	)	I-DNA	13	AMOD
16	day	day	B-NP	NN	I-DNA	17	NMOD
17	pi	pi	I-NP	NN	I-DNA	12	PMOD
18	.	.	O	.	O	6	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	showed	show	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	coccoid	coccoid	B-NP	JJ	O	7	NMOD
6	H.	H.	I-NP	NN	O	7	NMOD
7	pylori	pylori	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	4	SBAR
9	able	able	B-ADJP	JJ	O	8	PRD
10	to	to	B-VP	TO	O	11	VMOD
11	induce	induce	I-VP	VB	O	9	AMOD
12	an	an	B-NP	DT	O	15	NMOD
13	acute	acute	I-NP	JJ	O	15	NMOD
14	inflammatory	inflammatory	I-NP	JJ	O	15	NMOD
15	response	response	I-NP	NN	O	11	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	stomach	stomach	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	reinfected	reinfected	B-NP	JJ	O	20	NMOD
20	mice	mouse	I-NP	NNS	O	18	PMOD
21	since	since	B-PP	IN	O	11	VMOD
22	the	the	B-NP	DT	O	24	NMOD
23	initial	initial	I-NP	JJ	O	24	NMOD
24	periods	period	I-NP	NNS	O	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	infection	infection	B-NP	NN	O	25	PMOD
27	.	.	O	.	O	3	P

